Mefspas Tablet
By Mefspas
Rx
10 Tablet in a Strip

Composition
Dicyclomine(10mg) + Mefenamic Acid(250mg)

Manufacturer - Torque Pharmaceuticals Pvt Ltd
C-83, Industrial Area, Phase 7, Mohali, Punjab (INDIA) – 160055

Expires on or after
February, 2027

liver
When using Mefspas Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is advised to consult with your doctor regarding the use of Mefspas Tablet if you have liver issues.

kidney
Mefspas Tablet needs caution in kidney disease patients. Dosage adjustment may be necessary. Avoid in severe kidney disease. Consulting your doctor is advised.

alcohol
When taking Mefspas Tablet, be cautious if consuming alcohol. It's recommended to consult with your doctor regarding alcohol intake.

driving
Caution while driving is important when taking Mefspas Tablet. If you have symptoms that make it hard to focus or react, avoid driving. It is uncertain if Mefspas Tablet impacts driving ability.

pregnancy
It is better to consult your doctor before using Mefspas Tablet during pregnancy as information regarding its safety during this time is not available.

breastfeeding
It is better to consult your doctor before using Mefspas Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹28
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024